Industry Focus
Healthcare: What's Up With Mylan's EpiPen Pricing?
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:28:13
- Mais informações
Informações:
Sinopse
An EpiPen pricing debacle, an unexpected FDA rejection, and a sticker-shock inspiring M&A deal led to wild moves in Mylan N.V., Portola Pharmaceuticals, and Medivation this week.
